|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - BeiGene Ltd. (BGNE)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-06-27 Sale |
2019-07-01 8:28 pm |
BeiGene Ltd. | BGNE | Liang Howard CFO |
5,876 | $9.471 | $55,653 | 122,317 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-09-03 Sale |
2019-09-05 8:15 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
2,632 | $144.4 | 291,667 (Direct) |
View |
| 2019-09-03 Sale |
2019-09-05 8:15 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
230 | $144.9 | 291,667 (Direct) |
View |
| 2019-09-03 Sale |
2019-09-05 8:15 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
82 | $129.4 | 291,667 (Direct) |
View |
| 2019-08-23 Sale |
2019-08-27 4:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
714 | $143.9 | 357,926 (Direct) |
View |
| 2019-08-23 Exercise |
2019-08-27 4:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
7,900 | $31.59 | 357,926 (Direct) |
View |
| 2019-08-23 Sale |
2019-08-27 4:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
286 | $143 | 357,926 (Direct) |
View |
| 2019-08-23 Sale |
2019-08-27 4:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
6,700 | $145.1 | 357,926 (Direct) |
View |
| 2019-08-23 Sale |
2019-08-27 4:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
200 | $146.4 | 357,926 (Direct) |
View |
| 2019-08-23 Sale |
2019-08-27 4:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
714 | $145.3 | 357,926 (Direct) |
View |
| 2019-08-23 Exercise |
2019-08-27 4:04 pm |
N/A 2026-02-08 |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
102,700 | $2.43 | 357,926 (Direct) |
View |
| 2019-08-12 Other |
2019-08-14 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
13,384 | $0 | 3,711,426 (Direct) |
View |
| 2019-08-12 Other |
2019-08-14 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
26,100 | $0 | 3,711,426 (Direct) |
View |
| 2019-08-12 Exercise |
2019-08-13 4:47 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
2,500 | $45.31 | 850,465 (Direct) |
View |
| 2019-08-12 Sale |
2019-08-13 4:47 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
800 | $132.5 | 850,465 (Direct) |
View |
| 2019-08-12 Sale |
2019-08-13 4:47 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
400 | $134.3 | 850,465 (Direct) |
View |
| 2019-08-12 Sale |
2019-08-13 4:47 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
800 | $135.9 | 850,465 (Direct) |
View |
| 2019-08-12 Sale |
2019-08-13 4:47 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
500 | $136.9 | 850,465 (Direct) |
View |
| 2019-08-12 Exercise |
2019-08-13 4:47 pm |
N/A 2027-06-26 |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
32,500 | $3.49 | 850,465 (Direct) |
View |
| 2019-07-29 Exercise |
2019-07-31 4:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
5,000 | $45.31 | 1,044,775 (Direct) |
View |
| 2019-07-29 Exercise |
2019-07-31 4:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
5,130 | $29.49 | 1,044,775 (Direct) |
View |
| 2019-07-29 Sale |
2019-07-31 4:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
2,500 | $132.8 | 1,044,775 (Direct) |
View |
| 2019-07-29 Sale |
2019-07-31 4:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
7,630 | $135.1 | 1,044,775 (Direct) |
View |
| 2019-07-29 Exercise |
2019-07-31 4:04 pm |
N/A 2027-06-26 |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
65,000 | $3.49 | 1,044,775 (Direct) |
View |
| 2019-07-29 Exercise |
2019-07-31 4:04 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
66,690 | $2.27 | 1,044,775 (Direct) |
View |
| 2019-07-08 Sale |
2019-07-09 7:23 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,200 | $125.6 | 29,439,116 (Direct) |
View |
| 2019-07-08 Sale |
2019-07-09 7:23 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
719 | $127.2 | 29,439,116 (Direct) |
View |
| 2019-07-08 Sale |
2019-07-09 7:23 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,087 | $127.9 | 29,439,116 (Direct) |
View |
| 2019-07-08 Sale |
2019-07-09 7:23 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
100 | $128.8 | 29,439,116 (Direct) |
View |
| 2019-06-27 Sale |
2019-07-01 8:30 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
427 | $124.5 | 328,873 (Direct) |
View |
| 2019-06-27 Sale |
2019-07-01 8:30 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
3 | $126.3 | 328,873 (Direct) |
View |
| 2019-07-01 Sale |
2019-07-01 8:27 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chairman |
2,200 | $126.1 | 7,611,628 (Direct) |
View |
| 2019-07-01 Sale |
2019-07-01 8:27 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chairman |
2,647 | $126.7 | 7,611,628 (Direct) |
View |
| 2019-06-17 Other |
2019-06-18 10:41 am |
N/A N/A |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
9,282 | $0 | 0 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-11 08:25 am |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
64,610 | $9.23 | 64,610 (Direct) |
View |
| 2019-06-05 Other |
2019-06-07 6:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
182,539 | $0 | 10,749,251 (Indirect) |
View |
| 2019-06-05 Other |
2019-06-07 6:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
13,516 | $0 | 10,749,251 (Direct) |
View |
| 2019-06-05 Other |
2019-06-07 6:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
13,516 | $0 | 10,749,251 (Direct) |
View |
| 2019-06-05 Other |
2019-06-07 6:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
582,200 | $0 | 10,749,251 (Indirect) |
View |
| 2019-06-05 Other |
2019-06-07 6:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
43,109 | $0 | 10,749,251 (Direct) |
View |
| 2019-06-05 Other |
2019-06-07 6:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
43,109 | $0 | 10,749,251 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 6:28 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
129,220 | $9.23 | 10,749,251 (Indirect) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:18 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
62,842 | $0 | 462,579 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:18 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
462,579 | $9.23 | 462,579 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:17 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chairman |
747,708 | $9.23 | 747,708 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:15 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
75,855 | $0 | 558,285 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:15 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Liang Howard CFO |
558,285 | $9.23 | 558,285 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:14 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
64,610 | $9.23 | 64,610 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:13 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President |
433,472 | $0 | 1,505,956 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:13 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Wu Xiaobin President |
797,550 | $9.23 | 1,505,956 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:11 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | su Jingshyh S Director |
64,610 | $9.23 | 64,610 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:08 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
64,610 | $9.23 | 64,610 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:07 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Malley Thomas Director |
64,610 | $9.23 | 64,610 (Direct) |
View |
| 2019-06-05 Option Award |
2019-06-07 4:05 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,193,282 | $9.23 | 2,193,282 (Direct) |
View |
| 2019-05-20 Exercise |
2019-05-22 7:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
300 | $45.31 | 976,565 (Direct) |
View |
| 2019-05-20 Sale |
2019-05-22 7:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
300 | $130.1 | 976,565 (Direct) |
View |
| 2019-05-20 Exercise |
2019-05-22 7:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
2,200 | $45.31 | 976,565 (Direct) |
View |
| 2019-05-20 Sale |
2019-05-22 7:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
2,200 | $130.1 | 976,565 (Direct) |
View |
| 2019-05-20 Exercise |
2019-05-22 7:04 pm |
N/A 2027-06-26 |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
3,900 | $3.49 | 976,565 (Direct) |
View |
| 2019-05-20 Exercise |
2019-05-22 7:04 pm |
N/A 2027-06-26 |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
28,600 | $3.49 | 976,565 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 7:03 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
23,200 | $6.5 | 4,120,000 (Direct) |
View |
| 2019-05-21 Sale |
2019-05-22 7:03 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
23,200 | $130.2 | 4,120,000 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 7:03 pm |
N/A 2025-07-01 |
BeiGene Ltd. | BGNE | Liang Howard CFO |
301,600 | $0.5 | 4,120,000 (Direct) |
View |
| 2019-05-13 Sale |
2019-05-15 3:59 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
15,027 | $125.1 | 3,911,518 (Direct) |
View |
| 2019-05-06 Exercise |
2019-05-08 5:53 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
1,800 | $6.5 | 4,421,600 (Direct) |
View |
| 2019-05-06 Sale |
2019-05-08 5:53 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO |
1,800 | $130 | 4,421,600 (Direct) |
View |
| 2019-05-06 Exercise |
2019-05-08 5:53 pm |
N/A 2025-07-01 |
BeiGene Ltd. | BGNE | Liang Howard CFO |
23,400 | $0.5 | 4,421,600 (Direct) |
View |
| 2019-05-01 Sale |
2019-05-02 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President |
185 | $125.4 | 1,072,484 (Direct) |
View |
| 2019-05-01 Sale |
2019-05-02 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President |
5,657 | $124.5 | 1,072,484 (Direct) |
View |
| 2019-05-01 Sale |
2019-05-02 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President |
113 | $125.5 | 1,072,484 (Direct) |
View |
| 2019-05-01 Sale |
2019-05-02 4:07 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,402 | $124.8 | 29,439,116 (Direct) |
View |
| 2019-05-01 Sale |
2019-05-02 4:07 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,371 | $125.5 | 29,439,116 (Direct) |
View |
| 2019-05-01 Sale |
2019-05-02 4:07 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
51 | $126.5 | 29,439,116 (Direct) |
View |
| 2019-04-08 Exercise |
2019-04-10 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
14,130 | $29.49 | 1,111,465 (Direct) |
View |
| 2019-04-08 Sale |
2019-04-10 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
800 | $140.5 | 1,111,465 (Direct) |
View |
| 2019-04-08 Sale |
2019-04-10 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
3,439 | $141.8 | 1,111,465 (Direct) |
View |
| 2019-04-08 Sale |
2019-04-10 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
6,159 | $142.7 | 1,111,465 (Direct) |
View |
| 2019-04-08 Sale |
2019-04-10 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
2,304 | $143.7 | 1,111,465 (Direct) |
View |
| 2019-04-08 Sale |
2019-04-10 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
1,281 | $144.9 | 1,111,465 (Direct) |
View |
| 2019-04-08 Sale |
2019-04-10 6:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
147 | $145.9 | 1,111,465 (Direct) |
View |
| 2019-04-08 Exercise |
2019-04-10 6:41 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
183,690 | $2.27 | 1,111,465 (Direct) |
View |
| 2019-03-14 Sale |
2019-03-18 6:30 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
14,973 | $136.1 | 4,106,869 (Direct) |
View |
| 2019-03-13 Gift |
2019-03-14 4:25 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
18,577 | $0 | 7,677,031 (Direct) |
View |
| 2019-03-13 Gift |
2019-03-14 4:25 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
2,392 | $0 | 7,677,031 (Direct) |
View |
| 2019-03-07 Sale |
2019-03-11 7:38 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
71 | $140.5 | 1,295,155 (Direct) |
View |
| 2019-03-07 Exercise |
2019-03-11 7:38 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
2,565 | $29.49 | 1,295,155 (Direct) |
View |
| 2019-03-07 Sale |
2019-03-11 7:38 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
2,565 | $130 | 1,295,155 (Direct) |
View |
| 2019-03-07 Exercise |
2019-03-11 7:38 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
33,345 | $2.27 | 1,295,155 (Direct) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,502 | $151.3 | 29,439,116 (Direct) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,686 | $152.5 | 29,439,116 (Direct) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
200 | $153.7 | 29,439,116 (Direct) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
200 | $154.5 | 29,439,116 (Direct) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,233 | $151.5 | 29,439,116 (Direct) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,958 | $152.4 | 29,439,116 (Direct) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
600 | $154.3 | 29,439,116 (Direct) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
6,090 | $150.8 | 29,439,116 (Indirect) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,700 | $151.6 | 29,439,116 (Indirect) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,700 | $152.6 | 29,439,116 (Indirect) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
300 | $154.4 | 29,439,116 (Indirect) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,000 | $150.5 | 29,439,116 (Indirect) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,921 | $151.6 | 29,439,116 (Indirect) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,665 | $152.4 | 29,439,116 (Indirect) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
444 | $154.1 | 29,439,116 (Indirect) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
200 | $154.9 | 29,439,116 (Indirect) |
View |
| 2019-03-04 Sale |
2019-03-06 6:32 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
100 | $150 | 29,439,116 (Indirect) |
View |
| 2019-03-01 Sale |
2019-03-05 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
1,300 | $138.5 | 7,695,608 (Indirect) |
View |
| 2019-03-01 Sale |
2019-03-05 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
100 | $139.5 | 7,695,608 (Indirect) |
View |
| 2019-03-01 Sale |
2019-03-05 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
200 | $143.6 | 7,695,608 (Indirect) |
View |
| 2019-03-01 Sale |
2019-03-05 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
200 | $145.9 | 7,695,608 (Indirect) |
View |
| 2019-03-01 Sale |
2019-03-05 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
200 | $147.5 | 7,695,608 (Indirect) |
View |
| 2019-03-01 Sale |
2019-03-05 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
1,000 | $150 | 7,695,608 (Indirect) |
View |
| 2019-03-01 Sale |
2019-03-05 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
600 | $152.1 | 7,695,608 (Indirect) |
View |
| 2019-03-01 Sale |
2019-03-05 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
200 | $152.9 | 7,695,608 (Indirect) |
View |
| 2019-03-01 Sale |
2019-03-05 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
200 | $154.1 | 7,695,608 (Indirect) |
View |
| 2019-03-01 Sale |
2019-03-05 4:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
1,000 | $150 | 7,695,608 (Direct) |
View |
| 2018-12-17 Exercise |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
9,859 | $29.1 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
900 | $130.4 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
2,700 | $131.8 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
1,700 | $132.9 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
1,005 | $133.8 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
778 | $135 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
2,296 | $136.2 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
480 | $136.9 | 951,833 (Direct) |
View |
| 2018-12-17 Exercise |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
10,141 | $29.1 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
1,631 | $131.7 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
1,897 | $132.7 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
2,402 | $133.9 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
3,600 | $134.8 | 951,833 (Direct) |
View |
| 2018-12-17 Sale |
2018-12-19 6:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
611 | $135.5 | 951,833 (Direct) |
View |
| 2018-12-17 Exercise |
2018-12-19 6:34 pm |
N/A 2026-08-21 |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
128,167 | $2.24 | 951,833 (Direct) |
View |
| 2018-12-17 Exercise |
2018-12-19 6:34 pm |
N/A 2026-08-21 |
BeiGene Ltd. | BGNE | Peterson Amy C. CMO Immuno-oncology |
131,833 | $2.24 | 951,833 (Direct) |
View |
| 2018-12-10 Sale |
2018-12-12 5:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
400 | $133.6 | 29,439,116 (Indirect) |
View |
| 2018-12-10 Sale |
2018-12-12 5:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
860 | $134.7 | 29,439,116 (Indirect) |
View |
| 2018-12-10 Sale |
2018-12-12 5:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,171 | $135.7 | 29,439,116 (Indirect) |
View |
| 2018-12-10 Sale |
2018-12-12 5:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,307 | $136.6 | 29,439,116 (Indirect) |
View |
| 2018-12-10 Sale |
2018-12-12 5:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
400 | $137.6 | 29,439,116 (Indirect) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
2,671 | $151 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
800 | $152 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
529 | $152.9 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
400 | $154.2 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
300 | $155.5 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
100 | $156.8 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
100 | $159.5 | 7,708,608 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 5:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
100 | $163.8 | 7,708,608 (Direct) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
200 | $135 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,000 | $136.8 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,400 | $138 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
968 | $139 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,605 | $140 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,100 | $141 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
805 | $142 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
200 | $139.6 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
200 | $141.1 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
800 | $142.4 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,629 | $143.7 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
3,475 | $144.6 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
4,148 | $145.4 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
800 | $146.4 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
500 | $143.7 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
800 | $144.7 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,000 | $145.9 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,575 | $146.7 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
1,000 | $147.8 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
2,190 | $148.9 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Sale |
2018-11-28 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN CEO |
800 | $149.7 | 29,439,116 (Indirect) |
View |
| 2018-11-26 Exercise |
2018-11-28 7:25 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
3,000 | $29.49 | 1,328,500 (Direct) |
View |
| 2018-11-26 Sale |
2018-11-28 7:25 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
3,000 | $139.6 | 1,328,500 (Direct) |
View |
| 2018-11-26 Exercise |
2018-11-28 7:25 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO Hematology |
39,000 | $2.27 | 1,328,500 (Direct) |
View |
| 2018-11-27 Gift |
2018-11-28 7:23 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Director |
89,999 | $0 | 7,773,608 (Direct) |
View |
| 2018-11-19 Gift |
2018-11-21 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
3,138 | $0 | 4,133,802 (Direct) |
View |
| 2018-11-19 Gift |
2018-11-21 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
3,138 | $0 | 4,133,802 (Direct) |
View |
| 2018-11-19 Gift |
2018-11-21 6:42 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Glazer Donald W. Director |
3,138 | $0 | 4,133,802 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Fri, 18 Oct 2019 18:40:36 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |